Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 18815565)


A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings.

Knudsen BS, Zhao P, Resau J, Cottingham S, Gherardi E, Xu E, Berghuis B, Daugherty J, Grabinski T, Toro J, Giambernardi T, Skinner RS, Gross M, Hudson E, Kort E, Lengyel E, Ventura A, West RA, Xie Q, Hay R, Vande Woude G, Cao B.

Appl Immunohistochem Mol Morphol. 2009 Jan;17(1):57-67. doi: 10.1097/PAI.0b013e3181816ae2.


A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.

Nitta H, Kelly BD, Padilla M, Wick N, Brunhoeber P, Bai I, Singh S, Ranger-Moore J, Bieniarz C, Tsuda H, Grogan TM.

Diagn Pathol. 2012 May 30;7:60. doi: 10.1186/1746-1596-7-60.


Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue.

Fairley JA, Gilmour K, Walsh K.

Curr Drug Targets. 2012 Nov;13(12):1475-87. Review.


Usefulness and efficiency of formalin-fixed paraffin-embedded specimens from laryngeal squamous cell carcinoma in HPV detection by IHC and PCR/DEIA.

Morshed K, Polz-Dacewicz M, Szymański M, Smoleń A.

Folia Histochem Cytobiol. 2010 Sep 30;48(3):398-402. doi: 10.2478/v10042-010-0025-z.


Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET).

Gruver AM, Liu L, Vaillancourt P, Yan SC, Cook JD, Roseberry Baker JA, Felke EM, Lacy ME, Marchal CC, Szpurka H, Holzer TR, Rhoads EK, Zeng W, Wortinger MA, Lu J, Chow CK, Denning IJ, Beuerlein G, Davies J, Hanson JC, Credille KM, Wijayawardana SR, Schade AE.

Histopathology. 2014 Dec;65(6):879-96. doi: 10.1111/his.12510. Epub 2014 Oct 6.


A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections.

Wang X, Campoli M, Cho HS, Ogino T, Bandoh N, Shen J, Hur SY, Kageshita T, Ferrone S.

J Immunol Methods. 2005 Apr;299(1-2):139-51. Epub 2005 Apr 1.


Toward operative in vivo fluorescence imaging of the c-Met proto-oncogene for personalization of therapy in ovarian cancer.

Liu S, Zheng Y, Volpi D, El-Kasti M, Klotz D, Tullis I, Henricks A, Campo L, Myers K, Laios A, Thomas P, Ng T, Dhar S, Becker C, Vojnovic B, Ahmed AA.

Cancer. 2015 Jan 15;121(2):202-13. doi: 10.1002/cncr.29029. Epub 2014 Sep 10.


Characterization of anti-TIMP-1 monoclonal antibodies for immunohistochemical localization in formalin-fixed, paraffin-embedded tissue.

Sorensen IV, Fenger C, Winther H, Foged NT, Lademann U, Brünner N, Usher PA.

J Histochem Cytochem. 2006 Oct;54(10):1075-86. Epub 2006 Mar 3.


Quantitation of p95HER2 in paraffin sections by using a p95-specific antibody and correlation with outcome in a cohort of trastuzumab-treated breast cancer patients.

Sperinde J, Jin X, Banerjee J, Penuel E, Saha A, Diedrich G, Huang W, Leitzel K, Weidler J, Ali SM, Fuchs EM, Singer CF, Köstler WJ, Bates M, Parry G, Winslow J, Lipton A.

Clin Cancer Res. 2010 Aug 15;16(16):4226-35. doi: 10.1158/1078-0432.CCR-10-0410. Epub 2010 Jul 27.


Comparison of different antibodies for detection of progesterone receptor in breast cancer.

Press M, Spaulding B, Groshen S, Kaminsky D, Hagerty M, Sherman L, Christensen K, Edwards DP.

Steroids. 2002 Aug;67(9):799-813.


Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy.

Bagley RG, Rouleau C, Weber W, Mehraein K, Smale R, Curiel M, Callahan M, Roy A, Boutin P, St Martin T, Nacht M, Teicher BA.

Microvasc Res. 2011 Nov;82(3):253-62. doi: 10.1016/j.mvr.2011.09.004. Epub 2011 Sep 17.


p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry.

Kerns BJ, Jordan PA, Moore MB, Humphrey PA, Berchuck A, Kohler MF, Bast RC Jr, Iglehart JD, Marks JR.

J Histochem Cytochem. 1992 Jul;40(7):1047-51.


Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.

Sadi AM, Wang DY, Youngson BJ, Miller N, Boerner S, Done SJ, Leong WL.

BMC Cancer. 2011 Jun 16;11:253:1-13. doi: 10.1186/1471-2407-11-25.


Application of selected reaction monitoring for multiplex quantification of clinically validated biomarkers in formalin-fixed, paraffin-embedded tumor tissue.

Hembrough T, Thyparambil S, Liao WL, Darfler MM, Abdo J, Bengali KM, Hewitt SM, Bender RA, Krizman DB, Burrows J.

J Mol Diagn. 2013 Jul;15(4):454-65. doi: 10.1016/j.jmoldx.2013.03.002. Epub 2013 May 11.


Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.

Dahl E, En-Nia A, Wiesmann F, Krings R, Djudjaj S, Breuer E, Fuchs T, Wild PJ, Hartmann A, Dunn SE, Mertens PR.

BMC Cancer. 2009 Nov 24;9:410. doi: 10.1186/1471-2407-9-410.


Validation and comparison of anti-αvβ3 and anti-αvβ5 rabbit monoclonal versus murine monoclonal antibodies in four different tumor entities.

Böger C, Kalthoff H, Goodman SL, Röcken C.

Appl Immunohistochem Mol Morphol. 2013 Dec;21(6):553-60. doi: 10.1097/PAI.0b013e318284a03a.


Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative system.

Belloni B, Lambertini C, Nuciforo P, Phillips J, Bruening E, Wong S, Dummer R.

J Clin Pathol. 2013 Feb;66(2):124-35. doi: 10.1136/jclinpath-2012-200983. Epub 2012 Nov 3.


[Comparative genomic classification of human hepatocellular carcinoma].

Kaposi-Novák P.

Magy Onkol. 2009 Mar;53(1):61-7. doi: 10.1556/MOnkol.53.2009.1.9. Hungarian.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk